Clinical Trials Directory

Trials / Unknown

UnknownNCT00706212

The Accuracy of CHOLINE PET CT in the Diagnosis of Urological Malignancies

A Comparative Study to Examine the Accuracy of CHOLINE PET CT in the Diagnosis

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Rabin Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

PET CT is one of the imaging tools that are used for staging of urological malignancies. C11 Choline is a novel isotope with the advantage of its minimal secretion in the urine. This advantage makes it a potentially better metabolic marker then others such as FDG. Preliminary studies showed \~95% sensitivity in the diagnosis of TCC. Our Goal is to continue the evaluation of this method as a diagnostic and follow up tool in different urological malignancies.

Conditions

Timeline

Start date
2008-06-01
First posted
2008-06-27
Last updated
2008-06-27

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00706212. Inclusion in this directory is not an endorsement.